What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q3 2018?

146 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q3 2018. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class: Equity / Common Stock
Shares outstanding: 113,177,462
Total 13F shares: 43,213,947
Share change: +11,675,744
Total reported value: $752,787,195
Put/Call ratio: 100%
Price per share: $17.42
Number of holders: 146
Value change: +$280,535,030
Number of buys: 102
Number of sells: 50

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2018
Previous quarter: Q2 2018

Recent filing periods for CUSIP 92686J106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Avoro Capital Advisors LLC	13F	Company	4%	4,471,300	$42,433,000	—	30 Jun 2018	13F
Boxer Capital, LLC	13F	Company	3.3%	3,750,000	$35,588,000	—	30 Jun 2018	13F
BlackRock Finance, Inc.	13F	Company	2.6%	2,938,645	$27,888,000	—	30 Jun 2018	13F
VANGUARD GROUP INC	13F	Company	2.1%	2,369,190	$22,484,000	—	30 Jun 2018	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.8%	2,060,286	$19,552,000	—	30 Jun 2018	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.5%	1,723,982	$16,361,000	—	30 Jun 2018	13F
Opaleye Management Inc.	13F	Company	1.1%	1,200,000	$11,388,000	—	30 Jun 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.69%	782,424	$7,425,000	—	30 Jun 2018	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.66%	750,000	$7,118,000	—	30 Jun 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.65%	740,604	$7,028,000	—	30 Jun 2018	13F
STATE STREET CORP	13F	Company	0.65%	731,568	$6,943,000	—	30 Jun 2018	13F
Pier Capital, LLC	13F	Company	0.51%	579,853	$5,503,000	—	30 Jun 2018	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.47%	534,753	$5,074,000	—	30 Jun 2018	13F
Nicholas Investment Partners, LP	13F	Company	0.46%	516,791	$4,904,000	—	30 Jun 2018	13F
NORTHERN TRUST CORP	13F	Company	0.44%	492,845	$4,678,000	—	30 Jun 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.39%	443,271	$4,206,000	—	30 Jun 2018	13F
Park West Asset Management LLC	13F	Company	0.37%	414,107	$3,930,000	—	30 Jun 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.35%	396,011	$3,758,000	—	30 Jun 2018	13F
Informed Momentum Co LLC	13F	Company	0.33%	369,082	$3,503,000	—	30 Jun 2018	13F
Bank of New York Mellon Corp	13F	Company	0.31%	346,029	$3,284,000	—	30 Jun 2018	13F
MACQUARIE GROUP LTD	13F	Company	0.29%	330,100	$3,133,000	—	30 Jun 2018	13F
Sio Capital Management, LLC	13F	Company	0.25%	281,304	$2,670,000	—	30 Jun 2018	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.24%	267,247	$2,536,000	—	30 Jun 2018	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.23%	255,000	$2,420,000	—	30 Jun 2018	13F
David M. Knott	13F	Individual	0.22%	246,600	$2,340,000	—	30 Jun 2018	13F
BARCLAYS PLC	13F	Company	0.21%	238,953	$2,267,000	—	30 Jun 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.19%	216,187	$2,052,000	—	30 Jun 2018	13F
GROUP ONE TRADING LLC	13F	Company	0.15%	174,855	$1,659,000	—	30 Jun 2018	13F
Asymmetry Capital Management, L.P.	13F	Company	0.14%	154,207	$1,463,000	—	30 Jun 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.14%	153,427	$1,456,000	—	30 Jun 2018	13F
Healthcare Value Capital, LLC	13F	Company	0.13%	150,000	$1,424,000	—	30 Jun 2018	13F
Cornerstone Capital, Inc.	13F	Company	0.13%	145,500	$1,381,000	—	30 Jun 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.12%	133,064	$1,253,000	—	30 Jun 2018	13F
Global IMC LLC	13F	Company	0.1%	115,781	$1,099,000	—	30 Jun 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	115,096	$1,092,000	—	30 Jun 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.09%	101,846	$967,000	—	30 Jun 2018	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.09%	100,000	$949,000	—	30 Jun 2018	13F
MORGAN STANLEY	13F	Company	0.09%	98,136	$931,000	—	30 Jun 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.09%	96,734	$918,000	—	30 Jun 2018	13F
SEI INVESTMENTS CO	13F	Company	0.08%	92,565	$878,000	—	30 Jun 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.08%	92,100	$875,000	—	30 Jun 2018	13F
CREDIT SUISSE AG/	13F	Company	0.08%	86,488	$821,000	—	30 Jun 2018	13F
Russell Investments Group, Ltd.	13F	Company	0.08%	85,310	$810,000	—	30 Jun 2018	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.08%	85,000	$807,000	—	30 Jun 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.07%	83,430	$792,000	—	30 Jun 2018	13F
J. Goldman & Co LP	13F	Company	0.07%	82,698	$785,000	—	30 Jun 2018	13F
UBS Group AG	13F	Company	0.07%	82,201	$780,000	—	30 Jun 2018	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	79,512	$755,000	—	30 Jun 2018	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.07%	79,476	$754,000	—	30 Jun 2018	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.07%	77,911	$739,000	—	30 Jun 2018	13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q3 2018

As of 30 Sep 2018, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 146 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,213,947 shares. The largest 10 holders included FMR LLC, STATE STREET CORP, BlackRock Inc., Vanguard Group Inc, ArrowMark Colorado Holdings LLC, Park West Asset Management LLC, Balyasny Asset Management LLC, CITADEL ADVISORS LLC, JANUS HENDERSON GROUP PLC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 146 institutional shareholders reporting positions in this security for the Q3 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

115

Q3 2018 holders

146

Holder diff

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 Value $	Q3 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.